Literature DB >> 8939129

Evidence for the risk of calcium channel blockers in hypertension was selective.

F W Hanna, J R Peters, J A Rees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8939129      PMCID： PMC2352561          DOI： 10.1136/bmj.313.7067.1259c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  How safe are calcium antagonists in hypertension and coronary heart disease?

Authors:  G Mancia; P A van Zwieten
Journal:  J Hypertens       Date:  1996-01       Impact factor: 4.844

Review 2.  Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?

Authors:  D G Beevers; P Sleight
Journal:  BMJ       Date:  1996-05-04

3.  Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

Authors:  C D Furberg; B M Psaty; J V Meyer
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

4.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.